JAK2 V617F inhibitor
Search documents
Cogent Biosciences (NasdaqGS:COGT) FY Conference Transcript
2026-01-13 17:17
Cogent Biosciences (NasdaqGS:COGT) FY Conference January 13, 2026 11:15 AM ET Company ParticipantsAndrew Robbins - President and CEOConference Call ParticipantsAnupam Rama - Senior Biotech AnalystNone - AnalystAnupam RamaWelcome, everyone, to the 44th Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama. I'm one of the Senior Biotech Analysts here at J.P. Morgan. I'm joined by my squad, Rathi Phinai, Joyce Zhao, and Priyanka Grover. Our first presenting company of the day is Cogent, and presenti ...
Cogent Biosciences (NasdaqGS:COGT) FY Earnings Call Presentation
2026-01-13 16:15
J.P. Morgan Annual Meeting January 13, 2026 Forward-Looking Statements and Risk Factors This presentation and the accompanying oral commentary contain forward-looking statements that involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward looking statements. All statements other than statements of historical fact could be deemed forward-looking, including ...